Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

FilaggrinHigh melanomas have active FGFR signaling and weak GNA14 and Th1 signatures.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Combining skin tissue pathology with genetics has greatly improved the diagnosis and understanding of certain skin diseases.

Understanding genetic variations in mice is crucial for studying skin, hair, or nail abnormalities.

The research identified new skin traits in mice, some linked to human skin conditions.

The study suggests that complement activation, not immunoglobulins, may be important in erythema nodosum leprosum.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Immunocompromised patients can develop skin and hair issues due to a virus.

Anti-CD19 therapy may help treat SLE and NMOSD.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A woman with IgG/IgA pemphigus was treated successfully with dapsone and steroids.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.